
BCAL
BDX.AXBCAL Diagnostics Limited Price (BDX.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
246,225,497
(16.7484)%Description
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is h... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.086-0.185
- Market Cap 35.13M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Diagnostics & Research
- ceo: Mr. Shane Ryan M.B.A.
- IPO Date: July, 21, 2021
- Country: AU
- Currency: AUD
- Headquaters: Sydney, NSW
- Employees: No Data
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
